Mounjaro is a newer medication that acts on both GLP-1 and GIP receptors, making it more effective than Ozempic for weight loss and blood sugar control in some patients
PROMOTES DETOXIFICATION: Glutathione conjugation (facilitated by glutathione transferase enzymes) helps contribute to detoxification by binding electrophiles that would otherwise bind to proteins or nucleic acids, resulting in cellular damage
These compounds contain identical active ingredients to Wegovy and Mounjaro but are formulated to meet individual patient needsincluding custom concentrations and injection schedules that standard commercial doses may not accommodate
As NAD+ levels decline with age, symptoms like fatigue, brain fog, and slower metabolism become more noticeable
Glucagon-like peptide-1 receptor agonists, aka GLP-1 drugs, were originally approved and used for treatment of Type 2 diabetes, with the first product debuting in 2005